Skip to content

Study · Not a test of the peptide alone · 2017

1 result

Transplantation of CD51+ Stem Leydig Cells: A New Strategy for the Treatment of Testosterone Deficiency.

Zang ZJ, Wang J, Chen Z, Zhang Y, Gao Y, Su Z, Tuo Y, Liao Y, Zhang M, Yuan Q, Deng C, Jiang MH, Xiang AP

Stem cells (Dayton, Ohio)5 Mar 2017Cited by 59 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  1. 01AnimalNot a test of Triptorelin (Trelstar, Decapeptyl) aloneAnimal study (in vivo)Mechanism

    In cell-transplanted rats, decapeptyl suppressed testosterone secretion.

    In plain wordsIn rats with transplanted cells, decapeptyl suppressed testosterone secretion.

    Outcome
    DecreaseTestosterone secretion suppression
    Study

    ratn: not reported in source

    EDS-treated rats with transplanted CD51-positive stem Leydig cells
    Outcome group
    Sex hormones and fertility · Endocrine and hormones

    Source sentences

    Summary
    these testosterone secretions could be suppressed by decapeptyl (a luteinizing hormone-releasing hormone agonist)
    1 context sentence
    Summary · context
    As a specific cytotoxin that eliminates Leydig cells (LCs) in adult rats, ethane dimethanesulfonate (EDS) was used to ablate LCs before the SLC transplantation.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:26 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.